Review
doi: 10.1158/1940-6207.CAPR-09-0032.
Epub 2009 Mar 31.
Targeting angiogenesis from premalignancy to metastases
Affiliations
- PMID: 19336719
- PMCID: PMC10031626
- DOI: 10.1158/1940-6207.CAPR-09-0032
Item in Clipboard
Review
Targeting angiogenesis from premalignancy to metastases
Cancer Prev Res (Phila).
2009 Apr.
No abstract available
Comment on
-
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.Cancer Prev Res (Phila). 2009 Apr;2(4):330-7. doi: 10.1158/1940-6207.CAPR-08-0213. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336729 Free PMC article.
Similar articles
-
Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging.Acad Radiol. 2000 Oct;7(10):800-11. doi: 10.1016/s1076-6332(00)80629-7. Acad Radiol. 2000. PMID: 11048878 Review. No abstract available.
-
Less is more.EMBO Rep. 2003 Sep;4(9):831-4. doi: 10.1038/sj.embor.embor934. EMBO Rep. 2003. PMID: 12949581 Free PMC article.
-
Angiogenesis: a "common denominator" of disease?J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):564-5. J Am Pharm Assoc (Wash). 2000. PMID: 10932469 Review. No abstract available.
-
Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy.Future Oncol. 2012 Jan;8(1):5-8. doi: 10.2217/fon.11.133. Future Oncol. 2012. PMID: 22149028 No abstract available.
-
[Research advancement of endogenous angiogenesis inhibitors].Ai Zheng. 2005 Mar;24(3):376-84. Ai Zheng. 2005. PMID: 15757547 Review. Chinese.
Cited by
-
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.Nat Rev Clin Oncol. 2011 Mar 1;8(4):210-21. doi: 10.1038/nrclinonc.2011.21. Nat Rev Clin Oncol. 2011. PMID: 21364524 Free PMC article. Review.
-
Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy.Clin Cancer Res. 2009 Aug 15;15(16):5020-5. doi: 10.1158/1078-0432.CCR-09-0095. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671869 Free PMC article. Review.
-
Convergence of nanotechnology and cancer prevention: are we there yet?Cancer Prev Res (Phila). 2014 Oct;7(10):973-92. doi: 10.1158/1940-6207.CAPR-14-0079. Epub 2014 Jul 24. Cancer Prev Res (Phila). 2014. PMID: 25060262 Free PMC article. Review.
-
Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers.Oncotarget. 2016 Feb 16;7(7):7970-8. doi: 10.18632/oncotarget.6699. Oncotarget. 2016. PMID: 26701889 Free PMC article.
-
Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancer.Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):26-32. doi: 10.1002/cam4.5107. Cancer Med. 2022. PMID: 36202607 Free PMC article. Review.
References
-
- Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58–61. - PubMed
-
- Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353–64. - PubMed
-
- Fontanini G, Calcinai A, Boldrini L, et al. Modulation of neoangiogenesis in bronchial preneoplastic lesions. Oncol Rep 1999;6:813–7. - PubMed
-
- Merrick DT, Haney J, Petrunich S, et al. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 2005;48:31–45. - PubMed
-
- Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
